Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis.

[1]  M. Chang,et al.  Increased aortic endothelial cell death and enhanced transendothelial macromolecular transport in streptozotocin-diabetic rats , 1993, Diabetologia.

[2]  K. Borch-Johnsen,et al.  Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors , 1987, Diabetologia.

[3]  B. Feldt-Rasmussen,et al.  Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria , 1986, Diabetologia.

[4]  K. Nørgaard,et al.  Transcapillary escape rate of albumin in hypertensive patients with Type 1 (insulin-dependent) diabetes mellitus , 2004, Diabetologia.

[5]  B. Nordestgaard,et al.  Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. , 2003, Atherosclerosis.

[6]  B. Nordestgaard,et al.  Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[7]  B. Nordestgaard,et al.  Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. , 2002, European heart journal.

[8]  S. Neubauer,et al.  Alterations in myocardial creatinine kinase (CK) and lactate dehydrogenase (LDH) isoenzyme‐distribution in a model of left ventricular dysfunction , 2001, European journal of heart failure.

[9]  P. Schnohr.  The Copenhagen City Heart Study : Østerbroundersøgelsen : tables with data from the third examination 1991-1994 , 2001 .

[10]  S. Jacob,et al.  Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. , 2000, Circulation.

[11]  E. Vicaut,et al.  Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. , 1999, Diabetes.

[12]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[13]  W. Cefalu,et al.  Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys. , 1998, Metabolism: clinical and experimental.

[14]  C Cobelli,et al.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. , 1998, Metabolism: clinical and experimental.

[15]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[16]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[17]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[18]  P. Guillausseau,et al.  Rapid Publication , 1971, Nature.

[19]  J. Jensen,et al.  Renal and systemic transvascular albumin leakage in severe atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[20]  A. Schmidt,et al.  Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  T. Lyons,et al.  Lipoprotein glycation and its metabolic consequences. , 1997, Diabetes.

[22]  B. Nordestgaard,et al.  Aortic permeability to LDL as a predictor of aortic cholesterol accumulation in cholesterol-fed rabbits. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[23]  B. Nordestgaard,et al.  Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  V. Lupu,et al.  [Jaundice with indirect bilirubinemia via the mother's milk]. , 1992, Pediatrie.

[25]  J. Clore,et al.  Increased Transcapillary Escape Rate of Albumin in Nondiabetic Men in Response to Hyperinsulinemia , 1990, Diabetes.

[26]  K. Jan,et al.  Role of dying endothelial cells in transendothelial macromolecular transport. , 1990, Arteriosclerosis.

[27]  S. Weinbaum,et al.  Transendothelial Transport of Low Density Lipoprotein in Association with Cell Mitosis in Rat Aorta , 1989, Arteriosclerosis.

[28]  D. B. Zilversmit,et al.  Comparison of Arterial Intimal Clearances of LDL from Diabetic and Nondiabetic Cholesterol‐fed Rabbits: Differences in Intimal Clearance Explained by Size Differences , 1989, Arteriosclerosis.

[29]  S. Stender,et al.  In vivo transfer of cholesterol from plasma into human aortic tissue. , 1987, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[30]  L. Kuller,et al.  SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.

[31]  S M Grundy,et al.  Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Sasaki,et al.  Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. , 1982, Biochimica et biophysica acta.

[33]  J L Witztum,et al.  Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity , 1982, Diabetes.

[34]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[35]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[36]  D. B. Zilversmit,et al.  Transfer of Plasma Lipoprotein Components and of Plasma Proteins into Aortas of Cholesterol‐Fed Rabbits , 1981, Arteriosclerosis.

[37]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .

[38]  C. Matthews,et al.  The theory of tracer experiments with 131I-labelled plasma proteins. , 1957, Physics in medicine and biology.

[39]  S. Ed.  Healing of bronchial stump under experimental conditions , 1957 .